This inventor holds 1 USPTO granted patent. Top assignee: W. L. Gore & Associates, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Innovations by John Ahern in Medical Device Technology
Introduction
John Ahern is a notable inventor based in Boston, MA, recognized for his contributions to medical device technology. He has developed innovative solutions aimed at addressing complex medical conditions, particularly those related to cardiac anomalies. His work has significant implications for improving patient outcomes in the field of cardiology.
Latest Patents
John Ahern holds a patent for an adjustable length patent foramen ovale (PFO) occluder and catch system. This invention encompasses devices, delivery systems, and techniques designed for the closure of physical anomalies, such as atrial septal defects and patent foramen ovale. The occluder is characterized by a substantially cylindrical form, featuring a distal side and a proximal side. A catch system is integrated to secure the deployed configuration, allowing the device to be introduced into the treatment site via a delivery sheath. Notably, the occluder includes an adjustable length center joint, enabling it to fit specific septal defects. Additionally, the catch member can also be adjusted in length, enhancing its functionality.
Career Highlights
John Ahern is affiliated with W. L. Gore & Associates, Inc., where he has made significant strides in the development of medical devices. His innovative approach and dedication to improving medical technology have positioned him as a key figure in his field.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues, including Timothy J. Fallon and Steven W. Opolski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.
Conclusion
John Ahern's contributions to the field of medical devices, particularly through his patented PFO occluder, exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements that enhance patient care and treatment options.